Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

CCT Venues

Oct 12, 2022 2:00 PM - Oct 13, 2022 10:30 PM

Level 32, 40 Bank Street, London, E14 5NR, United Kingdom

Pharmacovigilance Strategies Workshop

Engage in the sharing of good practices between industry representatives and seek advice from regulators in this unique workshop


DIA is known for working closely with Industry and Regulators to enable in-depth discussion on relevant topics and exchange of ideas between different stakeholders.

Join the DIA Pharmacovigilance Strategy Workshop to get the latest insights from experts and learn about different aspects of pharmacovigilance through interactive sessions. Participation will help you broaden your knowledge and stimulate the exchange of ideas with other professionals.

The Workshop aims to stimulate dialogue and share practical experiences: it offers an opportunity to network, engage and share best practices as well as solution driven interactive round table sessions allowing you to engage with experts from different backgrounds.

DIA Pharmacovigilance Hackathon
Forming teams around a hot topic in pharmacovigilance and using a facilitated design-thinking framework to identify concrete next steps and possibly answers to these important questions. Each team will be pre-formed as a multi-stakeholder unit, in order to promote an impartial discussion. Participants will benefit from each other's different backgrounds as a strong driver for lateral thinking and creative problem-solving with some of the brightest minds in the life sciences field.


  • The Future of Pharmacovigilance: What to Keep/Change?

More information on the registration to be divulged soon.

Featured topics

  • Pharmacovigilance Guidelines and Regulations Updates (EU, non-EU, Global)
  • Globalisation of PSMF : Practical Implementation
  • Lessons Learnt from the Experiences with COVID-19 Vaccines
  • Workshop: Future Changes and Challenges in PV
  • Data Science and Standards : Impact on Pharmacovigilance
  • Social Media and Patient Support Programmes
  • Medical devices, wearables, combination products
  • Cooperation between marketing authorisation holders


Want to learn more about Pharmacovigilance Strategies Workshop? You've come to the right site!


Who should attend?

Established professionals who are seeking to increase their network of like-minded colleagues; share their thoughts and practices with others; learn the most current regulatory views and gain practical knowledge in key areas in pharmacovigilance, including:

  • Signal management
  • Data Privacy
  • Risk Management Planning
  • PSMF maintenance
  • Clinical Trials

Professionals involved in:

  • Drug Safety/Pharmacovigilance
  • Risk Management, including Risk Evaluation and Mitigation Strategies (REMS)
  • Benefit-risk assessment and communication
  • Medical Product Safety Assessment
  • Regulatory Intelligence
  • Clinical Trials
  • Pharmaceuticals, biologics, combination products, devices
  • Clinical Research and Clinical Research Organizations
  • Pharmacoepidemiology
  • Academic Research Centers
  • Regulatory Agencies

Learning objectives

  • Connect with experts and colleagues in pharmacovigilance
  • Learn in an interactive format through exchange of ideas and in-depth discussion
  • Understand the regulators’ expectations around pharmacovigilance and how to manage these
  • Find the answers to the day-to-day challenges you face
  • Exchange experiences, and contribute to solutions

Short Course or Primer

To keep you at the forefront.

Oct 11, 2022

Pre-conference Workshop:

Improving / Digitalizing Risk Minimisation - How to get the message across?

Program Committee

  • Bianca  Mulder, PharmD, MPharm, MSc
    Bianca Mulder, PharmD, MPharm, MSc Pharmacovigilance Assessor
    Medicines Evaluation Board, Netherlands
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • James  Whitehead, MBA, MSc
    James Whitehead, MBA, MSc Senior Director, Device & Digital Safety
    AstraZeneca, United Kingdom
  • Francoise  Sillan, MD
    Francoise Sillan, MD EU1 UK QPPV
    Ipsen, France
  • Wendy  Huisman, PharmD
    Wendy Huisman, PharmD Director
    Vigifit, Netherlands
  • Shahin  Kauser
    Shahin Kauser Leading Senior Scientific Assessor
    MHRA, United Kingdom
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
  • Claudia   Ferreira
    Claudia Ferreira Scientific Programmes Specialist
    DIA, Switzerland

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.